Clinical Trial Update: Interleukin-12 in Treating Patients With Cancer in the Abdomen [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating interleukin-12 for abdominal cancers, including anal, colorectal, gallbladder, gastric, and pancreatic cancers, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Colorectal Cancer
• Gallbladder Cancer
• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anal Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED